Page last updated: 2024-09-04

nco 700 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

nco 700 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(nco 700)
Trials
(nco 700)
Recent Studies (post-2010)
(nco 700)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
15009,156187552

Protein Interaction Comparison

ProteinTaxonomynco 700 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iizuka, K; Kawaguchi, H; Takano, H; Yasuda, H1

Other Studies

1 other study(ies) available for nco 700 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor.
    Biochemical medicine and metabolic biology, 1991, Volume: 45, Issue:1

    Topics: Animals; Blood Platelets; Calpain; Cathepsin B; In Vitro Techniques; Indomethacin; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protease Inhibitors; Rabbits; Serotonin

1991